ArticleACS medicinal chemistry letters2025

Discovery of Reversible, Noncovalent Bruton's Tyrosine Kinase Inhibitors Targeting BTK C481S Mutation.

Debasis Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.